Dihydrotestosterone Receptors in the Human Prostate. I. Nuclear Concentration in Normal, Benign, and Malignant Tissues

References

• Arduino L J, , Veterans Administration Cooperative Urological Research Group, et al. Carcinoma of the prostate: Treatment comparisons. J Urol 1967; 98: 516–522
   Google Scholar
• Bruchovsky N, Wilson J D. The conversion of testosterone to 5-alpha-androstan-17-beta-01–3-one by rat prostate in vivo and in vitro. J Biol Chem 1968; 243: 2012–2021
   PubMed Web of Science ®Google Scholar
• Dupuy G M, Roberts K D, Bleau G, Chapdelaine A. Inhibition of prostatic 5α-reductase and 3α-hydroxyteroid dehydrogenase by two antiandrogens. J Steroid Biochem 1977; 8: 1145–1151
   Google Scholar
• Ekman P, Snochowski M, Dahlberg E, Bresson D, Hogberg B, Gustafsson J A. Steroid receptor content in cytosol from normal and hyperplastic human prostate. J Clin Endocrinol Metab 1979; 49: 205–215
   PubMedGoogle Scholar
• Habib F K, Lee I R, Stitch S R, Smith P H. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate. J Endocrinol 1977; 71: 99–107
   Google Scholar
• Hammond G L. Endogenous steroid levels in the human prostate from birth to old age: A comparison of normal and diseased tissues. J Endocrinol 1978; 78: 7–19
   PubMed Web of Science ®Google Scholar
• Health, Education, and Welfare. Vital Statistics of the United States. Mortality. 1975; Vol. II, Part A
   Google Scholar
• Hicks L L, Walsh P C. A microassay for the measurement of androgen receptors in human prostatic tissue. Steroids 1979; 33: 389–406
   PubMed Web of Science ®Google Scholar
• Huggins C, Hodges C V. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injections on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 293–297
   Google Scholar
• Jensen E V, Block B E, Smith S, Kyser K, De Sombre E R. Estrogen receptors and breast cancer response to adrenalectomy. Natl Cancer Inst Monograph 1971; 34: 55–59
   PubMedGoogle Scholar
• Jönsson G, Hogberg B. Treatment of advance prostatic carcinoma with Estracyt. Scand J Urol Nephrol 1971; 5: 103–108
   PubMedGoogle Scholar
• Lehoux J-G, Benard B, Elhilali M. Determination des recepteurs de la dihydrotestos-terone de la prostate humaine. 33rd Annual Meeting of the Canadian Urology Society, Quebec, 1978, June 28-July 1st.
   Google Scholar
• Lehoux J-G, Benard B, Elhilali M, Grondin F. Nuclear receptors in human prostatic tissues. Canadian Andrology, Canadian Fertility Societies, Meeting La Sapiniere, Quebec, Canada, 1978, September 14th
   Google Scholar
• Lehoux J-G, Benard B, Grondin F, Elhilali M. Identification and characterization of nuclear androgen receptor in human prostate. Arch Androl 1979; 2, Suppl. 1, abstract # 79.
   Google Scholar
• Lieskovsky G, Bruchovsky N. Assay of nuclear androgen receptor in human prostate. J Urol 1979; 121: 54–58
   Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, Randal R T. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Mainwairing W IP, Milroy E JG. Characterization of the specific androgen receptors in the human prostate gland. J Endocrinol 1973; 57: 371–384
   Google Scholar
• McGuire W L, Carbone P P, Vollmer E P. Estrogen receptors in human breast cancer. Raven Press, New York 1975
   Google Scholar
• Mellinger G T, Bailor J D, III., Arduino L J, the Veterans Administration Cooperative Urologist Research Group. Treatment and survival of patients with cancer of the prostate. J Surg Gynecol Obstet 1967; 124: 1011
   Google Scholar
• Menon M, Tananis C E, McLoughlin M G, Walsh P C. Androgen receptors in human prostatic tissue: A review. Cancer Treat Rep 1977; 61: 265–271
   PubMedGoogle Scholar
• Menon M, Tananis C E, McLoughlin M G, Lippman M E, Walsh P C. The measurement of androgen receptors in human prostatic tissue utilizing sucrose density centrifugation and a protamine precipitation assay. J Urol 1977; 117: 309–312
   PubMedGoogle Scholar
• Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51: 660–672
   Web of Science ®Google Scholar
• Shain S A, Boesel R W, Lamn D L, Radwin H M. Characterization of unoccupied and occupied androgen binding components of the hyperplastic human prostate. Steroids 1978; 31: 541–556
   PubMed Web of Science ®Google Scholar
• Siiteri P K, Wilson J D. Dihydrotestos-terone in prostatic hypertrophy. 1. The formation and content of dihydrotestosterone in the hypertrophic prostate in man. J Clin Invest 1970; 49: 1737–1745
   PubMed Web of Science ®Google Scholar
• Sirett D AN, Grant J K. Androgen binding in cytosols and nuclei of human benign hyperplastic prostatic tissue. J Endocrinol 1978; 77: 101–110
   PubMedGoogle Scholar
• Snochowski M, Pousette A, Ekman P, Bression D, Anderson L, Hogberg B, Gustafsson J A. Characterizations and measurement of androgen receptor in human benign and prostatic hyperplasia and prostatic carcinoma. J Clin Endocrinol Metab 1977; 45: 920–930
   PubMed Web of Science ®Google Scholar
• Walsh P C, Wilson J D. The induction of prostatic hypertrophy in the dog with andros-tanediol. J Clin Invest 1976; 7: 1093–1097
   Google Scholar
• Walsh P C, Hicks L L, Reiner W G, Trachtenberg J. The use of androgen receptors to predict the duration of hormonal response in prostatic cancer. American Urological Association Inc., Seventy-fourth Annual Meeting, New York, 1979; p73, May 13–17
   Google Scholar